Expression of glucose transporter-1 in Taiwanese patients with breast carcinoma - A preliminary report

Kaohsiung Journal of Medical Sciences

Volumn 22, Issue 7, 2006, Pages 339-345

  Kuo, Shou Jen ^b   Wu, Yao Chung ^b   Chen, Chun Ping ^b   Tseng, Hsin Shun ^b   Chen, Dar Ren ^a  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NONE

Author keywords

Breast carcinoma; Glucose transporter 1; Immunohistochemistry

Indexed keywords

ESTROGEN RECEPTOR; GLUCOSE TRANSPORTER 1; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; PARAMETER; PROGNOSIS; PROTEIN EXPRESSION; TAIWAN; TUMOR VOLUME;

EID: 33746898675     PISSN: 02575655     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1607-551x(09)70320-1     Document Type: Article

References (27)

1. Holm E, Hagmuller E, Staedt U, et al. Substrate balances across colonic carcinoma in humans. Cancer Res 1995;55:1373-8.
2. Minn H, Joensuu H, Ahonen A, et al. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer 1988;61:1776-81.
3. Hiraki Y, Rosen OM, Birnbaum MJ. Growth factors rapidly induce expression of the glucose transporter gene. J Biol Chem 1988;263:13655-62.
4. Merrall NW, Plevin R, Gould GW. Growth factors, mitogens, oncogenes and the regulation of glucose transport. Cell Signal 1993;5:667-75.
5. Mischoulon D, Rana B, Kotliar N, et al. Differential regulation of glucose transporter 1 and 2 mRNA expression by epidermal growth factor and transforming growth factor-beta in rat hepatocytes. J Cell Physiol 1992;153:288-96.
6. Rollins BJ, Morrison ED, Usher P, et al. Platelet-derived growth factor regulates glucose transporter expression. J Biol Chem 1988;263:16523-6.
7. Mueckler M. Facultative glucose transporters. Eur J Biochem 1994;219:713-25.
8. Ardridge W, Boado R, Farrell C. Brain-type glucose transporter (Glut1) is selectively localized to the blood-brain-barrier. J Biol Chem 1990;265:18035-10.
9. Roehner SC, Davies A, Baldwin SA, et al. The blood-nerve barrier is rich in glucose transporter. J Neurocytol 1988;17:173-8.
10. Kata K, Kasahara T, Kasahara M, et al. Localization of erythrocyte/HepG2-type glucose transporter (Glut1) in human placental villi. Cell Tissue Res 1992;267:407-12.
11. Voldstedlund M, Dabelsteen E. Expression of GLUT1 in stratified squamous epithelia and oral carcinoma from humans and rats. APMIS 1997;105:537-45.
12. Urstein DE, Hytiroglou P, Miller L, et al. GLUT1 glucose transporter expression in cholangiocarcinoma. Mod Pathol 11:1998;151A. [Abstract]
13. Burstein DE, Reder I, Weiser K, et al. GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions. Mod Pathol 1998;11:392-6.
14. Aber RS, Rathan A, Weiser KR, et al. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 1998;83:34-40.
15. Haber RS, Weiser KR, Pritzker A, et al. GLUT1 glucose transporter expression in benign and malignant thyroid nodules. Thyroid 1997;7:363-7.
16. Juarez D, Lechago LV, Somoano M. Glut1 expression in transitional cell carcinoma of the urinary bladder correlates with aggressive biologic behavior. Lab Invest 1996;74:75A. [Abstract]
17. McGrogan G, Mauriac L, Durand M, et al. Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MIB1, pS2 and GSTpi. Br J Cancer 1996;74:1458-65.
18. Mellanen P, Minn H, Grenman R, et al. Expression of glucose transporters in head-and-neck tumors. Int J Cancer 1994;56:622-9.
19. Nagase Y, Takata K, Moriyama N, et al. Immunohistochemical localization of glucose transporters in human renal cell carcinoma. J Urol 1995;153:798-801.
20. Wang BY, Kalir T, Sabo E, et al. Immunohistochemical staining of GLUT1 in benign hyperplastic, and malignant endometrial epithelia. Cancer 2000;88:2774-81.
21. Younes M, Brown RW, Stephenson M, et al. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer 1997;80:1046-51.
22. Younes M, Ertan A, Lechago LV, et al. Human erythrocyte glucose transporter (Glut1) is immunohistochemically detected as a late event during malignant progres-sion in Barrett's metaplasia. Cancer Epidemiol Biomarkers Prev 1997;6:303-5.
23. Younes M, Brown RW, Mody DR, et al. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Anticancer Res 1995;15:2895-8.
24. Laudanski P, Koda M, Kozlowski L, et al. Expression of glucose transporter GLUT-1 and estrogen receptors ER-alpha and ER-beta in human breast cancer. Neoplasma 2004;51:164-8.
25. Younes M, Lechago LV, Lechago J. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. Clin Cancer Res 1996;2:1151-4.
26. Brown RS, Wahl RL. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer 1993;72:2979-85.
27. Kang SS, Chun YK. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. Jpn J Cancer Res 2002;93:1123-8.